We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jose Karam

Jose A Karam MD, FACS

Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Dr. Karam is an Associate Professor in the Department of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He is certified by the American Board of Urology, and provides surgical care for men and women diagnosed with urologic malignancies, with a particular interest in renal, testicular and adrenal tumors. Dr. Karam received his bachelor's degree in Biology with Distinction and earned his medical degree with Distinction from the American University of Beirut. He completed a postdoctoral research fellowship in Tumor Biology in the Department of Urology at the University of Texas Southwestern Medical Center at Dallas, then completed Urology residency at the University of Texas Southwestern Medical Center at Dallas, followed by a two-year Urologic Oncology Fellowship in the Department of Urology at The University of Texas MD Anderson Cancer Center in Houston.

Dr. Karam’s primary clinical and research interest is renal cell carcinoma. He performs open surgery, laparoscopic surgery, as well as robotic surgery, individually tailored for the needs of patients with cancers of the kidney, testis and adrenal, with a special interest in surgery for locally advanced and locally recurrent disease. Dr. Karam has a research interest in integration of targeted therapy with surgery, sarcomatoid renal cell carcinoma, rare kidney cancer histologies including renal medullary carcinoma, mouse models of renal cell carcinoma and molecular markers. In collaboration with colleagues from urology and genitourinary medical oncology, he is also involved in clinical trials investigating targeted therapy prior to renal surgery. Dr. Karam has authored more than 160 articles in urologic oncology, including original research, book chapters, reviews, and invited editorials.

Dr. Karam is a member of the American Urological Association, the Society of Urologic Oncology, the American Society of Clinical Oncology, the American College of Surgeons, and the American Association for Cancer Research. He serves as a reviewer for over 20 journals, including Journal of Urology, European Urology, Urologic Oncology, BJU International, among others. Dr. Karam is also on the Editorial Board of BJU International, and serves as Associate Section Editor (Urologic Oncology) for Annals of Surgical Oncology, Section Editor (Urologic Oncology) for BMC Urology, and Associate Editor for Frontiers in Oncology (Genitourinary Oncology).


Dr. Karam reported no disclosures.